Citi Basic Materials Conference. Jim Collins. Senior Vice President, Performance Materials & Industrial Biosciences E. I. du Pont de Nemours & Company

Size: px
Start display at page:

Download "Citi Basic Materials Conference. Jim Collins. Senior Vice President, Performance Materials & Industrial Biosciences E. I. du Pont de Nemours & Company"

Transcription

1 Citi Basic Materials Conference December 3, 2013 New York City Jim Collins Senior Vice President, Performance Materials & Industrial Biosciences E. I. du Pont de Nemours & Company 1

2 Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company and allows investors to better evaluate the financial results of the company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations on non-gaap measures to GAAP are available on the Investor Center of under Key Financials & Filings. Forward Looking Statements During the course of this presentation we may make forward-looking statements or provide forward-looking information. All statements that address expectations or projections about the future are forward-looking statements. Some of these statements include words such as plans, expects, will, anticipates, "believes," intends, and estimates. Although they reflect our current expectations, these statements are not guarantees of future performance, but involve a number of risks, uncertainties, and assumptions. Some of those risk factors include: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; global economic and capital markets conditions; litigation and environmental matters; changes in laws and regulations or political conditions; business or supply disruptions; ability to protect and enforce the company s intellectual property rights and successful integration of acquired business and separation of underperforming or non-strategic assets. The company does not undertake to update any forward-looking statements as a result of future developments or new information. Developing Markets Total developing markets is comprised of Developing Asia, Developing Europe, Middle East & Africa, and Latin America. A detailed list of all developing countries is available on the Earnings News Release link on the Investor Center website at 2 2

3 Three Strategic Priorities To Increase The Value Of DuPont Ag & Nutrition 1. Extend our leadership across the high-value, sciencedriven segments of the Ag and Food value chain Bio-based Industrials 2. Develop worldleading industrial biotechnology capabilities to create transformational new bio-based businesses Advanced Materials 3. Strengthen and grow our leading position in differentiated highvalue materials and leverage new sciences Higher Growth, Higher Value Company By Building And Increasing Leveraging The Three Value World-Leading Of DuPont Positions 3

4 Ongoing Portfolio Enhancement Through Major M&A Safety & Protection 2012 Segment Sales Industrial Biosciences Agriculture Performance Coatings Performance Materials $34.8B* Electronics & Communications Performance Chemicals Nutrition & Health Positioning DuPont For Future Growth Higher Growth And Value With Reduced Cyclicality And Commoditization * Consolidated net sales from continuing operations. 4

5 Performance Materials & Industrial Biosciences 5

6 Performance Materials Delivering Strong Results Today Operating margins at 19% in 2012, above long term target Operating Earnings and Margin Performance $1,068 $1,032 $1,225 Favorable ethane feedstock environment Growth in emerging regions, disciplined portfolio management 17% 15% 19% Continued R&D investments to strengthen local innovation and application development Operating Earnings* Operating Margins (%) Long-Term Growth Targets: Sales 3-5% CAGR with 16-18% Margins *Excludes non-operating pension/opeb costs and significant items. See company website for detailed reconciliation of non-gaap measures. 6

7 Performance Materials Key Markets Markets Market CAGR Trends % of 2012 Sales Packaging 4-5% Convenience, affordability, enhanced performance, sustainability and down-gauging 11% Automotive 3-5% Durability, cost-efficiency, and light-weighting for improved fuel efficiency in autos 38% 3-5% Improved performance, durability, lower cost, reduced maintenance 29% Industrial/Construction Consumer/Electronics Personal Care 3-5% Advanced aesthetic solutions, added functionality, lightweight, impact resistance 22% 7

8 New DuPont Vizilon thermoplastic composite Structural materials Sheet, UD tape Added functionality with resins Manufacturing Stepwise strategy to control investment with market demand Enabling technology Part design Customer processing support Expand application development capability Active developments with ~15 major OEMs and Tier 1 suppliers Polyamide layer Combined under heat and pressure to make rigid sheet material Fiber textile 8

9 Industrial Biosciences Summary Early Stages of Our Growth Story 2011 earnings reflect impact of Danisco acquisition Steady improvement in operating margins Operating Earnings and Margin Performance $162 Leading market positions in core markets including detergents, animal nutrition, bio materials and bio refineries Key capabilities in bio processing, protein engineering $81 11% 14% Know how to design, build, and operate cell factories on an industrial scale Operating Earnings* Operating Margins (%) Long-Term Growth Targets: Sales 7-9% CAGR with 16-18% Margins * Excludes non-operating pension/opeb costs and significant items. See company website for detailed reconciliation of non-gaap measures. 9

10 Industrial Biosciences- Three bio-based segments, serving a diverse set of customers Business Units Market CAGR Markets Trends % of 2012 Sales Bioactives 5-10% Food, beverages, feed, detergents, personal care, textiles Population and income growth fueling core demand in animal nutrition and convenience Water and energy conservation for textile production and fabric care 57% Biomaterials 4-7% Carpet, apparel, automotive Retailer and consumer preference for the use of sustainable materials Feedstock supply diversification 19% Biorefineries 7-9% Carbohydrates, ethanol, butanol Global mandates for energy diversification, environmental concerns and rural development 24% 10

11 Capturing Value as the Technology Enabler in Advanced Biofuels Commercial Demonstration Facility: Capacity: 30 million gallons per year Location: Nevada, Iowa Products: Cellulosic ethanol, lignin co-product Feedstock: Corn stover Status: Construction underway, operational in 2014 Three Revenue Streams in Advanced Biofuels: Technology Licensing, Enzyme and fermentation microbe sales, biofuels sales 11

12 Leveraging Industrial Biosciences Capabilities 12

13 DuPont Participation in Biorefinery Value Chain From Seeds to Carbohydrates to Fuels & Chemicals Agricultural Inputs Plant Feedstocks Conversion to Sugars Bio/Chemical Processes Biofuels Biochemicals Improved Seeds Crop Protection Sugar Starch Ethanol Biobutanol Bio-PDO Biochemicals Cellulose Differentiated Products Biofuels DuPont s unique ability to leverage science throughout the value chain 13

14 Renewable Polymers are Commercial Denso radiator end-tank - Zytel RS Cell phones - Zytel RS Salomon ski boots - DuPont Hytrel RS 2009 Winner SPE Innovation Fisher wall anchors - Zytel RS Knoll Chair - Hytrel RS Toyota Resistor Blades - Sorona EP Superior Communications HHD cover - Hytrel RS Hutchinson/Fiat Diesel Fuel Lines - Zytel RS 2011 Finalist SPE Innovation Fuel Lines Zytel RS Active Layer carpet membrane - Hytrel RS 2011 Winner SPE Innovation 14

15 What We Expect to Deliver in 2014 Maintain momentum in Performance Materials Grow the value of Industrial Biosciences Selective Investments in Renewable Polymers Move forward to start up our Cellulosic Ethanol Plant in 2014 Accelerate the integration of IB across Advanced Materials Performance Materials and Industrial Biosciences 15

16 Copyright 2013 DuPont. All rights reserved. The DuPont Oval Logo, DuPont TM The miracles of science TM, and all products denoted with or TM are trademarks or registered trademarks of E. I. du Pont de Nemours and Company. 16